Diclofenac-bismuth complex: Synthesis, physicochemical, and biological evaluation

Drug Development and Industrial Pharmacy

Volumn 34, Issue 4, 2008, Pages 434-444

  Abuznaid, Mohammed ^a   Sallam, Al Sayed ^b   Hamdan, Imad ^a   Al Hussaini, Mayssa ^a   Bani Jaber, Ahmad ^a  

^a UNIVERSITY OF JORDAN   (Jordan)

^b International Pharmaceutical Research Center Amman   (Jordan)

Author keywords

Bismuth; Complexation; Diclofenac; Dissolution; Ulcerogenic activity

Indexed keywords

BISMUTH CITRATE; DICLOFENAC;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CAPILLARY ELECTROPHORESIS; COMPLEX FORMATION; CONTROLLED STUDY; DRUG MIXTURE; DRUG SOLUBILITY; DRUG STRUCTURE; INFRARED SPECTROSCOPY; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; RAT; STOICHIOMETRY; STOMACH ULCER; SUSPENSION; ULCEROGENESIS;

ADMINISTRATION, ORAL; ANIMALS; ANTI-INFLAMMATORY AGENTS; DICLOFENAC; ELECTROPHORESIS, CAPILLARY; MAGNETIC RESONANCE SPECTROSCOPY; MALE; ORGANOMETALLIC COMPOUNDS; PARTICLE SIZE; PRECIPITATION; RATS; RATS, WISTAR; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; STOMACH ULCER; SUSPENSIONS;

EID: 42049093421     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040701831686     Document Type: Article

References (14)

1. Andrade, A., Namora, S., Woisky, R., Wiezel, G., Najjar, R., & Sertié, J., et al. (2000). Synthesis and characterization of a diruthenium-ibuprofenato complex comparing its anti-inflammatory activity with that of a copper(II)-ibuprofenato complex. J. Inorg. Biochem., 81, 23-27.
2. Chandrasekar, M., Ravichandran M., Nanjan M., & Suresh, B. (2001). Synthesis and evaluation of a nonsteroidal anti-inflammatory polymeric prodrug for sustained and site specific delivery. Drug Dev. Ind. Pharm., 27, 959-964.
3. Dorado, P., Bercz, R., Caceres, M., & Lerena, A. (2003). Analysis of diclofenac and its metabolites by high-performance liquid chromatography: Relevance of CYP2C9 genotypes in diclofenac urinary metabolic ratios. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 789, 437-442.
4. ICH. (1996). Guidelines Q2B, Validation of analytical procedures: Methodology. Iki, N., Hoshino, H., & Yotsuyanagi, T. (2000). A capillary electrophoretic reactor with an electroosmosis control method for measurement of dissociation kinetics of metal complexes. Anal. Chem., 72, 4812-4820.
5. Jandik, P., & Bonn, G. (1993). Capillary electrophoresis of small molecules and ions. New York: Wiley-VCH.
6. Kenawi, I. M., Barsoum, B. N., & Youssef, M. A. (2005). Cetirizine dihydrochloride interaction with some diclofenac complexes. Eur. J. of Pharm. Sci., 26, 341-348.
7. Kovala-Demertzi, D. (2000). Transition metal complexes of diclofenac with potentially anti-inflammatory activity. J. Inorg. Biochem., 79, 153-157.
8. Lee, S. P. (1991). The mode of action of colloidal bismuth-subcitrate. Scand. J. Gastroenterol., 26, 1-6.
9. Mahony, D., Lim-Marrison, S., Bryden, L., Faulkner, G., Hoffman, P., & Agocs, L., et al. (1999). Antimicrobial activities of synthetic bismuth compounds against Clostridium difficile. J. Antimicrob. Chemother., 43, 582-588.
10. Peterson, S. P., & Killurman, I. (1996). Gastrointestinal effects of NSAIDs: Difficulties in detection and management. Postgrad. Med., 100, 131-132, 135-136, 141-143.
11. Sallman, R.(1986). The history of diclofenac. Amer. J. Med., 80, 29-33.
12. Santos, L. H., Feres, C. A., Melo, F. H., Coelho, M. M., Nothenberg, M. S., & Oga, S., et al. (2004). Anti-inflammatory, antinociceptive and ulcerogenic activity of a zinc-diclofenac complex in rats. Braz. J. of Med. and Biol. Res., 37, 1205-1213.
13. Sharma, J., Singla, A., & Dhawan, S. (2003). Zinc-naproxen complex: Synthesis, physicochemical and biological evaluates. Int. J. Pharm., 24, 217-227.
14. Silverstein, R. M., Bassler, C. C., & Morrill, T. C. (1991). Spectrometric identification of organic compounds (5th ed.; pp. 208-222). New York: John Wiley and Sons.